Cargando…
Lassa Virus Treatment Options
Lassa fever causes an approximate 5000 to 10,000 deaths annually in West Africa and cases have been imported into Europe and the Americas, challenging public health. Although Lassa virus was first described over 5 decades ago in 1969, no treatments or vaccines have been approved to treat or prevent...
Autores principales: | Hansen, Frederick, Jarvis, Michael A., Feldmann, Heinz, Rosenke, Kyle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067676/ https://www.ncbi.nlm.nih.gov/pubmed/33917071 http://dx.doi.org/10.3390/microorganisms9040772 |
Ejemplares similares
-
A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015) -
Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018) -
Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015) -
Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali
por: Sogoba, Nafomon, et al.
Publicado: (2016) -
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
por: Safronetz, David, et al.
Publicado: (2015)